Temasek Holdings’s Vir Biotechnology VIR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q3
Sell
-5,133,610
Closed -$126M 91
2023
Q2
$126M Sell
5,133,610
-681,362
-12% -$16.7M 0.73% 31
2023
Q1
$135M Buy
5,814,972
+104,462
+2% +$2.43M 0.8% 29
2022
Q4
$145M Sell
5,710,510
-326,311
-5% -$8.26M 0.84% 32
2022
Q3
$116M Buy
6,036,821
+434,268
+8% +$8.37M 0.7% 35
2022
Q2
$143M Hold
5,602,553
0.78% 31
2022
Q1
$144M Buy
5,602,553
+65,262
+1% +$1.68M 0.61% 33
2021
Q4
$232M Sell
5,537,291
-223,754
-4% -$9.37M 0.84% 30
2021
Q3
$251M Buy
5,761,045
+149,170
+3% +$6.49M 0.88% 26
2021
Q2
$265M Buy
5,611,875
+93,231
+2% +$4.41M 0.89% 25
2021
Q1
$283M Buy
5,518,644
+18,645
+0.3% +$956K 1.11% 20
2020
Q4
$147M Hold
5,499,999
0.63% 28
2020
Q3
$189M Hold
5,499,999
0.96% 19
2020
Q2
$225M Hold
5,499,999
1.35% 15
2020
Q1
$188M Hold
5,499,999
1.39% 16
2019
Q4
$69.2M Buy
+5,499,999
New +$69.2M 0.45% 30